Prenatal Cocaine Exposure

Scientific Considerations and Policy Implications

Published in: Cocaine Report (New York: New York Academy of Sciences, 2000), 27 p

Posted on on January 01, 2000

by Suzanne L. Wenzel, Barry E. Kosofsky, John A. Harvey, Martin Y. Iguchi, Paul S. Steinberg, Katherine E. Watkins, Rashid Shaikh

Prenatal exposure to drugs, including cocaine, is a significant and preventable cause of developmental disability. Almost two decades after the nation first heard stories of "crack babies," new research has shown that children exposed to cocaine before birth are at risk of learning and behavioral problems. Such problems have broad implications for education, social welfare, and criminal justice in the United States. This report presents an overview of the current state of knowledge regarding the effect of cocaine on the developing brain and offers policy considerations for addressing the issues that arise from cocaine use by pregnant women. Most of the scientific research discussed in the report is derived from a 1997 New York Academy of Sciences conference titled: Cocaine: Effects on the Developing Brain (Harvey and Kosofsky, 1998). The policy considerations developed by the authors are based on this conference and on a series of investigations conducted by researchers at RAND under the leadership of Dr. Gail Zellman. The report is organized around four preventive strategies: primary prevention (preventing substance use before and during pregnancy); secondary prevention (identifying pregnant women who use drugs and minimizing their drug use); tertiary prevention (reducing the adverse consequences of substance exposure on children who were exposed in utero); and, finally, a rationale for making more resources available for women and children affected by cocaine.

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.